Zacks Research Reduces Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Zacks Research lowered their Q1 2026 earnings per share estimates for shares of Henry Schein in a research report issued on Thursday, October 17th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $1.41 for the quarter, down from their previous estimate of $1.42. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share.

Several other equities research analysts also recently commented on the company. JPMorgan Chase & Co. decreased their price objective on Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a report on Monday, August 12th. Robert W. Baird dropped their price objective on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 7th. Barrington Research reissued an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a research report on Friday, September 20th. Baird R W upgraded shares of Henry Schein from a "hold" rating to a "strong-buy" rating in a report on Monday, July 22nd. Finally, UBS Group cut their price target on Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein presently has a consensus rating of "Hold" and a consensus target price of $77.50.

Henry Schein Stock Down 1.1 %

Henry Schein stock traded down $0.80 during midday trading on Monday, reaching $71.59. The stock had a trading volume of 735,009 shares, compared to its average volume of 1,332,133. The company has a fifty day moving average price of $70.40 and a two-hundred day moving average price of $69.85. Henry Schein has a 12 month low of $60.01 and a 12 month high of $82.63. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $9.17 billion, a P/E ratio of 24.46, a PEG ratio of 1.98 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company's revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 earnings per share.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the company's stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.14% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HSIC. Summit Securities Group LLC purchased a new position in shares of Henry Schein during the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein during the second quarter worth about $37,000. Blue Trust Inc. boosted its position in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company's stock worth $60,000 after purchasing an additional 475 shares during the period. Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Henry Schein by 282.1% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company's stock valued at $109,000 after purchasing an additional 1,100 shares during the period. Finally, Palisade Asset Management LLC bought a new stake in shares of Henry Schein in the first quarter valued at approximately $113,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.